Operating Income for Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's current operating income (TTM) is $127.66B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
NVO
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$127.66B
YoY change
-0.5%
5Y CAGR
+18.7%
Peak year (2024)
$128.34B
Cumulative operating income
$1.03T
Operating Income history chart for Novo Nordisk (NVO) from 1985 to 2025
Operating Income history table for Novo Nordisk (NVO) from 1985 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $127.66B | -0.5% | ||
| 2024 | $128.34B | +25.1% | ||
| 2023 | $102.57B | +37.1% | ||
| 2022 | $74.81B | +27.6% | ||
| 2021 | $58.64B | +8.3% | ||
| 2020 | $54.13B | +3.1% | ||
| 2019 | $52.48B | +11.1% | ||
| 2018 | $47.25B | -3.5% | ||
| 2017 | $48.97B | +1.1% | ||
| 2016 | $48.43B | -2.0% | ||
| 2015 | $49.44B | +43.3% | ||
| 2014 | $34.49B | +9.5% | ||
| 2013 | $31.49B | +6.9% | ||
| 2012 | $29.47B | +31.7% | ||
| 2011 | $22.37B | +18.4% | ||
| 2010 | $18.89B | +26.5% | ||
| 2009 | $14.93B | +20.4% | ||
| 2008 | $12.40B | +38.5% | ||
| 2007 | $8.95B | -1.8% | ||
| 2006 | $9.12B | +12.9% | ||
| 2005 | $8.08B | +14.9% | ||
| 2004 | $7.03B | +9.8% | ||
| 2003 | $6.40B | +7.2% | ||
| 2002 | $5.97B | +6.7% | ||
| 2001 | $5.60B | +31.9% | ||
| 2000 | $4.24B | +45.3% | ||
| 1999 | $2.92B | +103.8% | ||
| 1998 | $1.43B | -38.6% | ||
| 1997 | $2.33B | +17.9% | ||
| 1996 | $1.98B | +5.7% | ||
| 1995 | $1.87B | +1.8% | ||
| 1994 | $1.84B | -5.3% | ||
| 1993 | $1.94B | +67.8% | ||
| 1992 | $1.16B | -17.5% | ||
| 1991 | $1.40B | +33.4% | ||
| 1990 | $1.05B | +0.2% | ||
| 1989 | $1.05B | +12.1% | ||
| 1988 | $936.24M | +44.6% | ||
| 1987 | $647.45M | -3.2% | ||
| 1986 | $668.90M | -8.8% | ||
| 1985 | $733.26M | — |
Operating Income values are taken from Novo Nordisk's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
Analysis
In 2025, Novo Nordisk (NVO) operating income totalled $127.66B – edged down 0.5% year-over-year.
Over 2020–2025 (5 years), Novo Nordisk operating income expanded at a +18.7% compound annual rate, with the latest reading among the more recent periods of the dataset.
The dataset's maximum operating income sits at $128.34B (2024); the minimum reading of $647.45M dates to 1987.
Novo Nordisk (NVO) sits 1st of 8 Healthcare peers we track on this metric, against a peer median of $19.53B.
Novo Nordisk Operating Income by Year
Novo Nordisk Operating Income 2025: $127.66B
Novo Nordisk operating income in 2025 was $127.66B, edged down 0.5% below 2024.
Novo Nordisk Operating Income 2024: $128.34B
Novo Nordisk operating income in 2024 was $128.34B, grew 25.1% from 2023. This figure represents the highest annual value in the available history.
Novo Nordisk Operating Income 2023: $102.57B
Novo Nordisk operating income in 2023 was $102.57B, surged 37.1% from 2022.
Novo Nordisk Operating Income 2022: $74.81B
Novo Nordisk operating income in 2022 was $74.81B, grew 27.6% from 2021.
Novo Nordisk Operating Income 2021: $58.64B
Novo Nordisk operating income in 2021 was $58.64B.
See more financial history for Novo Nordisk (NVO).
Sector peers — Operating Income
Companies in the same sector as Novo Nordisk, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $8.11B | Healthcare |
Frequently asked questions
What is Novo Nordisk's operating income?
- Latest reported operating income for Novo Nordisk (NVO) is $127.66B (period ending December 31, 2025).
How has Novo Nordisk operating income changed year-over-year?
- Novo Nordisk (NVO) operating income changed -0.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Novo Nordisk operating income?
- Novo Nordisk (NVO) operating income compound annual growth rate is +18.7% over the most recent 5 years available.
When did Novo Nordisk operating income hit its highest annual value?
- Novo Nordisk operating income reached its highest annual value of $128.34B in 2024.
What was Novo Nordisk operating income in 2024?
- Novo Nordisk (NVO) operating income in 2024 was $128.34B.
What was Novo Nordisk operating income in 2025?
- Novo Nordisk (NVO) operating income in 2025 was $127.66B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
NVO Overview
Company profile, financial tools, and key metrics
NVO Revenue Counter
Earns 9,800 DKK every second. See per minute, hour, and day.
NVO Earnings Counter
Earns 3,248 DKK per second net profit. See per minute, hour, and day.
NVO What If Invested
What if you had invested $1,000? See historical returns from any date.
NVO How It Makes Money
Discover visual breakdown of 309.06B DKK in revenue — where it comes from and where it goes.
NVO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
NVO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
NVO Daily Price Character
Balanced · 47.3% historical win rate (green days). Streaks & record days.
NVO Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
NVO Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
NVO Dividend Profile
Yield: 4.62%. Safety: 5/8. See full history.
NVO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
NVO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.